The post Gold holds near record high, eyes $5,600 as safe-haven demand persists appeared on BitcoinEthereumNews.com. Gold (XAU/USD) maintains its strong bid toneThe post Gold holds near record high, eyes $5,600 as safe-haven demand persists appeared on BitcoinEthereumNews.com. Gold (XAU/USD) maintains its strong bid tone

Gold holds near record high, eyes $5,600 as safe-haven demand persists

Gold (XAU/USD) maintains its strong bid tone near the all-time peak through the early European session on Thursday, eyeing the $5,600 mark amid a supportive fundamental backdrop. Investors continue to seek refuge in traditional safe-haven assets on the back of heightened geopolitical and economic uncertainties, which have been fueling the commodity’s parabolic rise of more than 10% since the beginning of this week. Apart from this, the recent US Dollar (USD) slump to its lowest level since February 2022 turns out to be another factor behind the precious metal’s blistering rally for the ninth straight day.

Meanwhile, the non-yielding Gold seems rather unaffected by US Federal Reserve (Fed) Chair Jerome Powell’s hawkish remarks on Wednesday that followed the highly anticipated decision to leave interest rates unchanged. Even the underlying bullish tone – as depicted by a generally positive sentiment around the equity markets – does little to hinder the bullion’s strong positive momentum. This, in turn, suggests that the path of least resistance for the XAU/USD pair remains to the upside, though extremely overbought conditions warrant caution for bulls before positioning for any further appreciation.

Daily Digest Market Movers: Gold buying persists as safe-haven demand drives record-breaking rally

  • Concerns that US tariff increases from last year continue to weigh on the global economic outlook resurfaced after Germany – the Eurozone’s biggest economy – on Wednesday lowered its growth forecasts for this and next year.
  • US President Donald Trump warned Iran to come to the table and make a deal on nuclear weapons, or future US attacks would be far worse. Iran responded with a threat to strike against the US, Israel, and those who support them.
  • In other geopolitical developments, Russia continues with its aerial attacks on Ukrainian cities and infrastructure. The latest attack involved a Russian drone strike on a passenger train in northeastern Ukraine that killed five people.
  • This, along with the emergence of fresh US Dollar selling, assists the safe-haven Gold to prolong the record-setting rally for the ninth straight day and climb to the $5,600 neighborhood during the Asian session on Thursday.
  • The US Federal Reserve, as was anticipated, decided to leave rates unchanged at the end of a two-day meeting on Wednesday. Two Fed Governors – Stephen Miran and Christopher Waller – dissented in favor of a 25 basis-points cut.
  • In the post-meeting press conference, Fed Chair Jerome Powell said that inflation was still well above the 2% target. The muted market reaction, however, suggests that investors remain concerned about threats to the Fed’s independence.
  • A criminal investigation of Powell by the Department of Justice and an evolving effort to fire Fed Governor Lisa Cook put the focus on the freedom of monetary authorities from direct political interference in formulating policies.
  • Meanwhile, traders seem convinced that the Fed will maintain the status quo through the end of this quarter and possibly until Chair Jerome Powell’s tenure ends in May, though they are still pricing in two more rate cuts in 2026.
  • The outlook, in turn, fails to assist the US Dollar to build on the previous day’s modest recovery from a nearly four-year low and turns out to be another factor that provides an additional boost to the non-yielding yellow metal.
  • Traders now look to Thursday’s release of the usual Weekly Initial Jobless Claims data from the US for a short-term impetus. The supportive fundamental backdrop, however, remains tilted firmly in favor of the XAU/USD bulls.

Gold uptrend remains uninterrupted despite overbought RSI

The overnight breakout through a short-term ascending channel hurdle near $5,303.94 keeps the bullish tone intact. Moreover, the Moving Average Convergence Divergence (MACD) line extends above the Signal line, with both above zero, and the histogram is widening, suggesting strengthening upside momentum.

However, the Relative Strength Index (RSI) sits at 88 (overbought), which could cap immediate advances and prompt a pause. Should momentum cool, initial support aligns with the channel’s lower boundary at $5,135.11, where buyers could re-emerge. A contraction in the MACD histogram would hint at a fading impulse, while the RSI easing from overbought would normalize conditions; even so, holding above former channel resistance would preserve the broader bullish bias and keep pullbacks orderly within the rising structure.

(The technical analysis of this story was written with the help of an AI tool.)

US Dollar Price Last 7 Days

The table below shows the percentage change of US Dollar (USD) against listed major currencies last 7 days. US Dollar was the strongest against the Canadian Dollar.

USDEURGBPJPYCADAUDNZDCHF
USD-2.50%-3.02%-3.32%-2.28%-4.52%-3.96%-3.73%
EUR2.50%-0.52%-0.84%0.23%-2.06%-1.49%-1.27%
GBP3.02%0.52%-0.32%0.76%-1.55%-0.98%-0.76%
JPY3.32%0.84%0.32%1.06%-1.25%-0.70%-0.44%
CAD2.28%-0.23%-0.76%-1.06%-2.28%-1.73%-1.50%
AUD4.52%2.06%1.55%1.25%2.28%0.58%0.81%
NZD3.96%1.49%0.98%0.70%1.73%-0.58%0.22%
CHF3.73%1.27%0.76%0.44%1.50%-0.81%-0.22%

The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the US Dollar from the left column and move along the horizontal line to the Japanese Yen, the percentage change displayed in the box will represent USD (base)/JPY (quote).

Source: https://www.fxstreet.com/news/gold-extends-record-breaking-streak-as-safe-haven-demand-persists-202601290437

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26